DK1218001T3 - Ultrafint L-carnitin, fremgangsmåder til fremstilling deraf, sammensætninger indeholdende det og fremgangsmåder til anvendelse deraf - Google Patents

Ultrafint L-carnitin, fremgangsmåder til fremstilling deraf, sammensætninger indeholdende det og fremgangsmåder til anvendelse deraf

Info

Publication number
DK1218001T3
DK1218001T3 DK00961529T DK00961529T DK1218001T3 DK 1218001 T3 DK1218001 T3 DK 1218001T3 DK 00961529 T DK00961529 T DK 00961529T DK 00961529 T DK00961529 T DK 00961529T DK 1218001 T3 DK1218001 T3 DK 1218001T3
Authority
DK
Denmark
Prior art keywords
methods
carnitine
ultrafine
preparation
compositions containing
Prior art date
Application number
DK00961529T
Other languages
Danish (da)
English (en)
Inventor
Ken Hassen
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26849378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1218001(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of DK1218001T3 publication Critical patent/DK1218001T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
DK00961529T 1999-09-03 2000-09-05 Ultrafint L-carnitin, fremgangsmåder til fremstilling deraf, sammensætninger indeholdende det og fremgangsmåder til anvendelse deraf DK1218001T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15224099P 1999-09-03 1999-09-03
US15824599P 1999-10-08 1999-10-08
PCT/US2000/024279 WO2001017525A1 (en) 1999-09-03 2000-09-05 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same

Publications (1)

Publication Number Publication Date
DK1218001T3 true DK1218001T3 (da) 2009-04-14

Family

ID=26849378

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00961529T DK1218001T3 (da) 1999-09-03 2000-09-05 Ultrafint L-carnitin, fremgangsmåder til fremstilling deraf, sammensætninger indeholdende det og fremgangsmåder til anvendelse deraf

Country Status (17)

Country Link
US (2) US20020111383A1 (de)
EP (1) EP1218001B1 (de)
JP (3) JP2003508488A (de)
KR (1) KR100827900B1 (de)
CN (1) CN1399549A (de)
AT (1) ATE418978T1 (de)
AU (1) AU770563B2 (de)
CA (1) CA2383814C (de)
CY (1) CY1110223T1 (de)
DE (1) DE60041269D1 (de)
DK (1) DK1218001T3 (de)
ES (1) ES2322328T3 (de)
HK (1) HK1047889B (de)
MX (1) MXPA02002327A (de)
NZ (1) NZ517597A (de)
PT (1) PT1218001E (de)
WO (1) WO2001017525A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169770B2 (en) 2001-04-24 2007-01-30 Lonza Ltd. Method of enhancing reproductive performance in sows
WO2002085134A1 (en) * 2001-04-24 2002-10-31 Lonza Ltd. Method of enhancing reproductive performance in sows
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
DE20321010U1 (de) * 2003-03-28 2005-12-29 Schymura, Martin Fruchtgummizusammensetzung
EP2289504A3 (de) * 2003-07-01 2012-05-23 President and Fellows of Harvard College SIRT1 Modulatoren zur Veränderung der Lebensdauer/Stressreaktion von Zellen/Organismen
CA2548671C (en) 2003-12-29 2015-02-24 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
JP4539096B2 (ja) * 2004-01-16 2010-09-08 日油株式会社 油性成分被覆ｌ−カルニチン塩粉末およびその用途
JP2008503479A (ja) * 2004-06-16 2008-02-07 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Ｂａｘ媒介性アポトーシスを調節する方法及び組成物
WO2006004722A2 (en) * 2004-06-30 2006-01-12 Biomol Research Laboratories, Inc. Compositions and methods for selectively activating human sirtuins
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
EP1901715B1 (de) * 2005-07-05 2012-05-02 Lonza AG Sprühtrockenverfahren zur herstellung eines trockenen carnitin-pulvers oder -granulats
DE102007009649A1 (de) 2007-02-26 2008-08-28 Beiersdorf Ag Nahrungsergänzungsmittel zur Pflege und/oder Verschönerung der Haut
DE102007009650A1 (de) 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
CN101224202A (zh) * 2007-12-26 2008-07-23 广州康采恩医药有限公司 减肥组合物
AU2015283905B2 (en) 2014-07-03 2020-10-22 NAN Global, LLC Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes
WO2017105090A1 (ko) * 2015-12-14 2017-06-22 제이투에이치바이오텍 (주) 오로트산 l-카르니틴의 결정질 다형체, 이의 제조방법 또는 용도
EP3855944A4 (de) * 2018-10-29 2022-06-29 Lonza Consumer Health Inc. Verfahren und zusammensetzung zur erhöhung der bioverfügbarkeit von carnitin
CN112250588B (zh) * 2020-11-06 2023-03-31 哈尔滨工业大学（深圳） 一种左旋肉碱离子液体及其制备方法、应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156852B (it) * 1978-07-10 1987-02-04 Sigma Tau Ind Farmaceuti Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni
EP0150688B1 (de) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salze von L-Carnitin und Alkanoyl-L-Carnitinen sowie Verfahren zur Herstellung derselben
IT1172394B (it) * 1983-12-28 1987-06-18 Sigma Tau Ind Farmaceuti Sali della l-carnitina e di alcuni alcanoil derivati della l-carnitina e procedimento per la loro preparazione
US5057597A (en) * 1990-07-03 1991-10-15 Koskan Larry P Process for the manufacture of anhydro polyamino acids and polyamino acids
IT1256705B (it) * 1992-12-21 1995-12-12 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
JPH08259445A (ja) * 1995-01-27 1996-10-08 Takeda Chem Ind Ltd 胃排出能改善性医薬組成物
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
IT1289974B1 (it) * 1997-02-25 1998-10-19 Aldo Fassi Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine
JP4160634B2 (ja) * 1996-05-31 2008-10-01 シグマ―タウ インダストゥリー ファーマチェウティケ リウニーテ ソシエタ ペル アチオニ Ｌ（―）カルニチンおよびアルカノイルｌ（―）カルニチン類の安定な非吸湿性塩、それらの製造方法並びに該塩を含有する固形の経口投与可能な組成物
US6488961B1 (en) * 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
DE69715456T2 (de) * 1996-12-03 2003-02-27 Univ Kansas State Verwendung von carnitin-angereicherte futter für trächtige säue
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6149939A (en) * 1997-05-09 2000-11-21 Strumor; Mathew A. Healthful dissolvable oral tablets, and mini-bars
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US6090849A (en) * 1999-03-23 2000-07-18 The Board Of Regents For Oklahoma State University Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
US6476010B2 (en) * 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals

Also Published As

Publication number Publication date
KR100827900B1 (ko) 2008-05-07
HK1047889B (zh) 2009-04-09
CY1110223T1 (el) 2015-01-14
JP2003508488A (ja) 2003-03-04
JP2009067809A (ja) 2009-04-02
CA2383814C (en) 2010-08-17
MXPA02002327A (es) 2004-07-16
DE60041269D1 (de) 2009-02-12
PT1218001E (pt) 2009-03-31
ES2322328T3 (es) 2009-06-19
AU770563B2 (en) 2004-02-26
JP2013136635A (ja) 2013-07-11
NZ517597A (en) 2003-11-28
US20050124558A1 (en) 2005-06-09
CN1399549A (zh) 2003-02-26
US20020111383A1 (en) 2002-08-15
EP1218001A4 (de) 2005-05-18
CA2383814A1 (en) 2001-03-15
EP1218001A1 (de) 2002-07-03
US7303765B2 (en) 2007-12-04
HK1047889A1 (en) 2003-03-14
KR20020066322A (ko) 2002-08-14
ATE418978T1 (de) 2009-01-15
AU7347000A (en) 2001-04-10
EP1218001B1 (de) 2008-12-31
WO2001017525A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
CY1110223T1 (el) Υπερλεπτη l-καρνιτινη μεθοδοι παρασκευης της, συνθεσεις που την περιεχουν και μεθοδοι χρησεως της
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
EP1399414A4 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
IL159022A0 (en) Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
CY1107810T1 (el) Συνθεσεις οι οποιες εχουν ενα συνδυασμο χαρακτηριστικων αμεσης απελευθερωσης και ελεγχομενης απελευθερωσης
DE60204612D1 (de) Metallkoordinationsverbindung, Lumineszente Vorrichtung und Bildanzeigevorrichtung
WO2002046188A3 (en) Amido ether substituted imidazoquinolines
EP1187613A4 (de) Amid-substituierte Imidazochinoline
EP1671949A3 (de) Substituierte phenylamine und pyridinylamine
EP1448187A4 (de) Verbindungen aus einem aminnukleus und diese enthaltende pharmazeutische zusammensetzungen
ATE403425T1 (de) Feste formulierungen enthaltend eine indolinon verbindung
DE60221872D1 (de) Kugelförmiges monodisperses metallteilchen
AU2003295489A8 (en) Cis-prenyltransferases from the rubber-producing plants russian dandelion (taraxacum kok-saghyz) and sunflower (helianthus annus)
AU2002368224A8 (en) Metal nanoparticle thermoset and carbon compositions from mixtures of metallocene-aromatic-acetylene compounds
DE60104871D1 (de) Aminoplastvernetzungsmittel und pulverlack-zusammensetzungen die diese enthalten
DE60231082D1 (de) Nanopartikelzusammensetzungen enthaltend fenofibrat
ATE500835T1 (de) Entzündungshemmende zusammensetzungen und anwendungsverfahren
EP1558931A4 (de) Analyse pharmazeutischer löslichkeit und stabilität
WO2004092727A3 (en) Compound libraries and methods for drug discovery
MY128718A (en) Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
ITMI20022358A1 (it) Composizioni farmaceutiche effervescenti per la realizzazione di sospensioni non convenzionali.
ITRM20010364A1 (it) Ascorbil derivati di carnitine e composizioni cosmetiche contenenti tali derivati.
FR2890564B1 (fr) Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
DK1444247T3 (da) Tibolonformuleringer
GB0227373D0 (en) The invention relates to high concentrations low volume and substantially dry and free flowing powders containing insecticides